Arkolith/Insider Trading/INTS/Form 4

Bender Lewis H

President and CEO, Director, 10% OwnerINTENSITY THERAPEUTICS, INC. (INTS) · full profile →Form 4 · filed Mar 7, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2024Grant(A)465K—$0465K
Mar 6, 2024Grant(A)34K—$034K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-020830) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML